Drugs / cefuroxime axetil

Regulatory milestones approvals, filings & regulatory actions · 6 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansions (5) US (FDA) CEFTIN — 1992-01-31 – 1999-08-24 fda.gov ↗
Approved US (FDA) CEFTIN — 1987-12-28 fda.gov ↗

Trials 3

1987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT00000752 ? → Feb 1993 HIV infectious disease, sinusitis National Institute of Allergy and Infectious Diseases (NIAID) Withdrawn No outcome recorded
Phase not applicable2 trials
— NCT07512648 Mar 2026 → Apr 2028 expected breast disorder, granulomatous mastitis Caigang Liu Not yet recruiting No outcome recorded
— NCT02147249 Jul 2013 → Dec 2020 — University Medical Centre Ljubljana Unknown No outcome recorded
Comparator or background therapy3 trials
Phase 0 NCT02099240 Comparator Mar 2014 → Nov 2018 osteomyelitis University of Louisville Terminated No outcome recorded Stop: Enrollment
Phase 4 NCT01518192 Comparator Jun 2006 → Nov 2007 post-treatment Lyme disease syndrome University Medical Centre Ljubljana Completed No outcome recorded
— NCT03584919 Comparator Jun 2006 → Sep 2007 — University Medical Centre Ljubljana Completed No outcome recorded

Press releases naming this drug 1 release

DateIssuerRelease
2004-10-18 Teva Branded Pharmaceutical Products R&D, Inc. Teva Announces Approval Of Cefuroxime Axetil Tablets tevapharm.com ↗

Evidence & citations 19 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Cefuroxime Axetil “oral cefuroxime axetil tablets (brand name: Dalixin®), 250 mg twice daily” NCT07512648 ↗
5

“cefuroxime axetil orally, 500 mg, bid, 14 days” NCT02147249 ↗

“Cefuroxime axetil” NCT02099240 ↗

NCT03584919 ↗

NCT01518192 ↗

NCT00000752 ↗

Known as CCI 15641 ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Ceftin ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Cefurax ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Cefuroxime (as axetil) ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Cefuroxime 1-acetoxyethyl ester ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Cepazine ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Cetoxil ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Curocef ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Dalixin “oral cefuroxime axetil tablets (brand name: Dalixin®), 250 mg twice daily” NCT07512648 ↗
Known as Elobact ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Novador ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Novocef ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as NSC-758677 ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Oraxim ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Zinat ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Known as Zinnat ChEMBL registry synonym — accepted as the source's own label CHEMBL1095930 ↗
Modality Small molecule — CHEMBL1095930 ↗
Route Oral “cefuroxime axetil orally” NCT02147249 ↗